ITGAX and heart disorder: Minor differences were observed in levels of CD8, CD49e, and CD11c after treatment with hypoglycemic agents, and in levels of CD62P, CD42a, CD44, and CD31, after treatment with anticoagulants, in patients with organ damage and/or cardiac disease.